335 related articles for article (PubMed ID: 27317000)
1. High-Throughput Cell Toxicity Assays.
Murray D; McWilliams L; Wigglesworth M
Methods Mol Biol; 2016; 1439():245-62. PubMed ID: 27317000
[TBL] [Abstract][Full Text] [Related]
2. High-throughput assay development for combined in vitro toxicity screening of hit compounds and their metabolites in early drug-discovery stage.
Siricilla S
Bioanalysis; 2017 Jul; 9(13):959-961. PubMed ID: 28708435
[No Abstract] [Full Text] [Related]
3. High-throughput toxicity testing of chemicals and mixtures in organotypic multi-cellular cultures of primary human hepatic cells.
Orbach SM; Ehrich MF; Rajagopalan P
Toxicol In Vitro; 2018 Sep; 51():83-94. PubMed ID: 29751030
[TBL] [Abstract][Full Text] [Related]
4. High-throughput metabolism-induced toxicity assays demonstrated on a 384-pillar plate.
Yu KN; Kang SY; Hong S; Lee MY
Arch Toxicol; 2018 Aug; 92(8):2501-2516. PubMed ID: 29974144
[TBL] [Abstract][Full Text] [Related]
5. High throughput toxicity screening and intracellular detection of nanomaterials.
Collins AR; Annangi B; Rubio L; Marcos R; Dorn M; Merker C; Estrela-Lopis I; Cimpan MR; Ibrahim M; Cimpan E; Ostermann M; Sauter A; Yamani NE; Shaposhnikov S; Chevillard S; Paget V; Grall R; Delic J; de-Cerio FG; Suarez-Merino B; Fessard V; Hogeveen KN; Fjellsbø LM; Pran ER; Brzicova T; Topinka J; Silva MJ; Leite PE; Ribeiro AR; Granjeiro JM; Grafström R; Prina-Mello A; Dusinska M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27273980
[TBL] [Abstract][Full Text] [Related]
6. Design and Implementation of High-Throughput Screening Assays.
Powell DJ; Hertzberg RP; Macarrόn R
Methods Mol Biol; 2016; 1439():1-32. PubMed ID: 27316985
[TBL] [Abstract][Full Text] [Related]
7. Drug and bioactive molecule screening based on a bioelectrical impedance cell culture platform.
Ramasamy S; Bennet D; Kim S
Int J Nanomedicine; 2014; 9():5789-809. PubMed ID: 25525360
[TBL] [Abstract][Full Text] [Related]
8. Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening.
Paricharak S; IJzerman AP; Jenkins JL; Bender A; Nigsch F
J Chem Inf Model; 2016 Sep; 56(9):1622-30. PubMed ID: 27487177
[TBL] [Abstract][Full Text] [Related]
9. ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates.
White DT; Eroglu AU; Wang G; Zhang L; Sengupta S; Ding D; Rajpurohit SK; Walker SL; Ji H; Qian J; Mumm JS
Nat Protoc; 2016 Dec; 11(12):2432-2453. PubMed ID: 27831568
[TBL] [Abstract][Full Text] [Related]
10. Integrated in vitro-in silico screening strategy for the discovery of antibacterial compounds.
Nybond S; Ghemtio L; Nawrot DA; Karp M; Xhaard H; Tammela P
Assay Drug Dev Technol; 2015; 13(1):25-33. PubMed ID: 25710544
[TBL] [Abstract][Full Text] [Related]
11. Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety.
Meseguer-Ripolles J; Khetani SR; Blanco JG; Iredale M; Hay DC
AAPS J; 2017 Dec; 20(1):20. PubMed ID: 29270863
[TBL] [Abstract][Full Text] [Related]
12. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
[TBL] [Abstract][Full Text] [Related]
13. tcpl: the ToxCast pipeline for high-throughput screening data.
Filer DL; Kothiya P; Setzer RW; Judson RS; Martin MT
Bioinformatics; 2017 Feb; 33(4):618-620. PubMed ID: 27797781
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Assessment of Mechanistic Toxicity of Chemicals in Miniaturized 3D Cell Culture.
Joshi P; Kang SY; Datar A; Lee MY
Curr Protoc Toxicol; 2019 Feb; 79(1):e66. PubMed ID: 30387930
[TBL] [Abstract][Full Text] [Related]
15. Automated large-scale culture and medium-throughput chemical screen for modulators of proliferation and viability of human induced pluripotent stem cell-derived neuroepithelial-like stem cells.
McLaren D; Gorba T; Marguerie de Rotrou A; Pillai G; Chappell C; Stacey A; Lingard S; Falk A; Smith A; Koch P; Brüstle O; Vickers R; Tinsley J; Flanders D; Bello P; Craig S
J Biomol Screen; 2013 Mar; 18(3):258-68. PubMed ID: 23042076
[TBL] [Abstract][Full Text] [Related]
16. A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®.
Bircsak KM; DeBiasio R; Miedel M; Alsebahi A; Reddinger R; Saleh A; Shun T; Vernetti LA; Gough A
Toxicology; 2021 Feb; 450():152667. PubMed ID: 33359578
[TBL] [Abstract][Full Text] [Related]
17. High-throughput cell death assays.
Pamenter ME; Haddad GG
Methods Mol Biol; 2015; 1254():153-63. PubMed ID: 25431064
[TBL] [Abstract][Full Text] [Related]
18. Using the BioAssay Ontology for analyzing high-throughput screening data.
Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
[TBL] [Abstract][Full Text] [Related]
19. An Analysis of Different Components of a High-Throughput Screening Library.
Saha A; Varghese T; Liu A; Allen SJ; Mirzadegan T; Hack MD
J Chem Inf Model; 2018 Oct; 58(10):2057-2068. PubMed ID: 30204440
[TBL] [Abstract][Full Text] [Related]
20. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments.
Astashkina A; Grainger DW
Adv Drug Deliv Rev; 2014 Apr; 69-70():1-18. PubMed ID: 24613390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
